Neurocrine Bio. (NBIX) PT Raised to $125 at Needham & Company

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Neurocrine Bio. (NBIX) PT Raised to $125 at Needham & Company

Neurocrine Bio. (NBIX) PT Raised to $131 at Baird

August 1, 2018 6:58 AM EDT

Baird raised its price target on Neurocrine Bio. (NASDAQ: NBIX) to $131.00 (from $122.00) while maintaining an Outperform rating on continued strength in Ingrezza launch.

Analyst Brian Skorney commented, "Neurocrine reported earnings, with net sales of Ingrezza coming in well ahead of expectations at $96.9M.... More

Neurocrine Bio. (NBIX) PT Raised to $135 at Barclays

August 1, 2018 5:38 AM EDT

Barclays raised its price target on Neurocrine Bio. (NASDAQ: NBIX) to $135.00 (from $100.00) while maintaining a Overweight rating.

... More

Neurocrine Biosciences (NBIX) Tops Q2 EPS by 10c

July 31, 2018 4:04 PM EDT

Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of ($0.07), $0.10 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.

... More